Related Experiment Video

Updated: May 6, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy

Elisa Tran1, Annabelle Chow, Takeshi Goda

  • 1Biological Sciences, Sunnybrook Research Institute, Canada.

Biochemical and Biophysical Research Communications
|November 5, 2013
PubMed

Insights

Autophagy protein ATG4B

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Autophagy is a cellular process crucial for maintaining homeostasis.
  • ATG4B, a cysteine protease, is essential for autophagy.
  • Autophagy is an emerging target for cancer therapy, with ATG4B inhibitors under active development.

Purpose of the Study:

  • To investigate the role of ATG4B in anticancer therapy.
  • To determine the context-dependent effects of ATG4B modulation during cancer treatment.

Main Methods:

  • Overexpression of dominant-negative ATG4B(C74A) in PC-3 and C4-2 prostate cancer cells.
  • In vitro and in vivo experimental models were utilized.
  • Analysis of treatment outcomes in response to ATG4B(C74A) expression.

Main Results:

  • The impact of ATG4B(C74A) varied based on cell type, treatment, and experimental context.
  • ATG4B(C74A) expression could enhance the efficacy of cytotoxic therapies.
  • Conversely, ATG4B(C74A) expression was also observed to promote resistance to certain treatments.

Conclusions:

  • The role of ATG4B in cancer therapy is complex and context-specific.
  • Predictive biomarkers are essential for the successful clinical application of ATG4B inhibitors.
  • Further research is needed to elucidate the precise mechanisms underlying ATG4B's dual role in cancer treatment response.
Keywords:
ATG4BAutophagyChemotherapyProstate cancerRadiation therapy

More Related Videos

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

17.2K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K